硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
抗人 SCARA5 抗体对
试剂盒

抗人 SCARA5 抗体对

01AB01336

Scavenger receptor class A member 5 (SCARA5) is a cell surface protein. It forms a disulfide-linked homotrimer exceeding 250 kDa and is primarily expressed in testicular Sertoli and germ cells, with weaker expression in other epithelial tissues. Functionally, SCARA5 acts as a ferritin receptor mediating non-transferrin-dependent iron delivery by stimulating ferritin endocytosis, thus playing a critical role in intracellular iron homeostasis. It also binds bacterial particles but not yeast or modified LDL. SCARA5 is a positive regulator of adipocyte lineage commitment and early adipogenesis in mesenchymal stem cells, modulating differentiation through the FAK-ERK signaling pathway and glucocorticoid-induced expression. In disease contexts, SCARA5 suppresses proliferation and migration and promotes apoptosis in human retinoblastoma cells by inhibiting the PI3K/AKT pathway, suggesting a tumor suppressor role. Its dysregulation may impact cancer progression and metabolic disorders linked to iron metabolism and adipogenesis.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
SCARA5
蛋白别名
scavenger receptor class A member 5; SCARA5
UniProt
Q6ZMJ2
物种
Human

产品详情

靶点名称
SCARA5
蛋白名称
scavenger receptor class A member 5
蛋白别名
Scavenger receptor class A member 5; Scavenger receptor hlg
靶点基因名
SCARA5
UniProt
Q6ZMJ2
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Scavenger receptor class A member 5 (SCARA5) is a cell surface protein. It forms a disulfide-linked homotrimer exceeding 250 kDa and is primarily expressed in testicular Sertoli and germ cells, with weaker expression in other epithelial tissues. Functionally, SCARA5 acts as a ferritin receptor mediating non-transferrin-dependent iron delivery by stimulating ferritin endocytosis, thus playing a critical role in intracellular iron homeostasis. It also binds bacterial particles but not yeast or modified LDL. SCARA5 is a positive regulator of adipocyte lineage commitment and early adipogenesis in mesenchymal stem cells, modulating differentiation through the FAK-ERK signaling pathway and glucocorticoid-induced expression. In disease contexts, SCARA5 suppresses proliferation and migration and promotes apoptosis in human retinoblastoma cells by inhibiting the PI3K/AKT pathway, suggesting a tumor suppressor role. Its dysregulation may impact cancer progression and metabolic disorders linked to iron metabolism and adipogenesis.